News

Dermatology Times® welcomes 7 new members to its Editorial Advisory Board

The 11th annual New Frontiers in Cosmetic Medicine & Medical Dermatology Symposium agenda has been released. Click to see what this meeting has to offer.

In this week’s Pointers with Dr Portela, the 208SkinDoc compares 3 different fluid sunscreens to decided, in his opinion, which works best.

The EADV has revealed the findings from a recent survey shows almost half of all European adults have a dermatological condition.

This week’s edition of The Mainstream Patient features stories about HS flares during the period, clothes that double as skincare, and more!

Click here to answer our weekly poll.

Patients with skin conditions may be more likely to contract the disease but less likely to become severely ill.

A glimpse at what to expect from Dermatology Times this week.

In a grand rounds presentation at the Maui Derm NP+PA Fall 2021 conference, Seemal Desai, MD, FAAD, Raegan Hunt, MD, PhD, Ted Rosen, MD, and Matthew J. Zirwas, MD, discussed some of their challenging cases.

Learning to identify some well-disguised drivers of eczema and contact dermatitis can speed patients toward clear or almost clear, according to a presentation at Maui Derm NP+PA Fall 2021.

ICYMI, some of this week’s featured content includes a new Pointers with Dr Portela, and articles on Maui Derm NP+PA coverage, website slander, nail issues plus more.

Coppertone has issued a voluntary recall for 12 lots of its aerosol sunscreen, citing detected levels of the carcinogen benzene.

The Maui Derm NP+PA Fall 2021 8th Annual Meeting begins today with an in-person, 4-track preconference program at the Omni Grove Park Inn in Asheville, North Carolina. Continue to check in for the next 3 days for the latest coverage of the main program which is from September 30 to October 3.

In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, dives into the issues of nail care. She explains why nails peel, how to prevent it, and so much more!

This week’s edition of The Mainstream Patient features stories about PFR fillers, blue LED light therapy, female hair loss, infected piercing care, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes a new podcast episode on molecular targeting of biologics, and articles on pipeline updates for melanoma, treating various skin conditions in skin of color patients, and more.

Catch up on all of the latest news coming out of the Skin of Color Update 2021.

The FDA has announced steps at improving the quality, safety, and efficacy of sunscreens.

The announcement is part of a slate of new vaccine mandates announced Sept. 9.

The agency wants to give clarity to the Health Breach Notification Rule.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes FDA warnings about JAK inhibitors, and articles about laser treatment for lentigines, Image-Guided Superficial Radiotherapy for BCC and SCC, the risk of insomnia in vitiligo patients, plus more.

The drop in use was starkest in the northeast.

This week’s edition of The Mainstream Patient features stories about albinism, salt water for acne, curl gatekeeping, dry scalp, exercising with psoriatic arthritis, plus more.

A glimpse at what to expect from Dermatology Times this week.

Hilary Baldwin, MD, presents on keloids in light skin patients, hypopigmentation after treatment, to stitch or not to stitch, and more.

ICYMI, some of this week’s featured content includes what's trending in skincare for September 2021, and articles about pyschodermatology of acne in adolescents, drug related psoriasis, the link between psoriasis and dementia, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes a new podcast episode, and articles about a new black box warning for certain JAK inhibitors, guselkumab vs secukinumab, updates in lasers and light devices, plus more.